Equivac He V

GPTKB entity

Statements (54)
Predicate Object
gptkbp:instance_of gptkb:vaccine
gptkbp:administered_by gptkb:horse_race
gptkbp:approves gptkb:2012
gptkb:Australia
gptkbp:booster_required yes
gptkbp:clinical_trial conducted
prevention of Hendra virus infection
gptkbp:contraindication none known
gptkbp:developed_by gptkb:Zoetis
gptkbp:dosage_form 1 m L
gptkbp:formulation injection
https://www.w3.org/2000/01/rdf-schema#label Equivac He V
gptkbp:is_effective_against high
gptkbp:is_vulnerable_to gptkb:educational_campaigns
ongoing
government and private sectors
refrigerated
veterinary clinics
varies by provider
involves local stakeholders
based on research
between government and industry
based on risk assessment
advancements in veterinary medicine
trained personnel required
inactivated virus
contributes to global disease control
post-vaccination observation recommended
reduces Hendra virus outbreaks
reduces risk of disease
by Australian Pesticides and Veterinary Medicines Authority
gptkbp:manufacturer gptkb:Zoetis_Australia_Pty_Ltd.
gptkbp:regulatory_compliance registered
gptkbp:route_of_administration subcutaneous
gptkbp:safety generally safe
gptkbp:service_frequency gptkb:annually
gptkbp:side_effect mild swelling
gptkbp:storage 2-8° C
gptkbp:targets gptkb:Equus_caballus
gptkb:Hendra_virus
gptkbp:type equine vaccine
gptkbp:vaccine_adverse_reactions rare
gptkbp:vaccine_category preventive vaccine
gptkbp:vaccine_efficacy_studies peer-reviewed
gptkbp:vaccine_ethics considerations in development
gptkbp:vaccine_impact_studies ongoing research
gptkbp:vaccine_label contains instructions
gptkbp:vaccine_legislation mandatory in some regions
gptkbp:vaccine_public_health important for equine and human health
gptkbp:vaccine_research_institutions collaborative efforts
gptkbp:vaccine_shelf_life 2 years
gptkbp:vaccine_usage in endemic areas
gptkbp:bfsParent gptkb:Hendra_virus
gptkbp:bfsLayer 7